being and becoming in the world
Kings College London [KCL] has received over £800,000 from Janssen for Esketamine research. Professor Allan Young, Vice Dean and Clinical Academic Lead for KCL, features in this Guardian “Exclusive” [from … Continue reading The promotion of ESKETAMINE
In September 2019 the following paper was published in the Lancet Psychiatry [the full open-access paper can be accessed here): Alongside the publication of the PANDA Trial in the Lancet … Continue reading Published and unpublished comments on the PANDA trial
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”
There has long been awareness of the effects of Ketamine use among those who have taken it unprescribed. Given the lack of long term data on this specific “new therapeutic … Continue reading “We should cautiously welcome this new therapeutic option”